Minerva Neurosciences

Filed a patent for "gastro-resistant controlled release oral dosage forms" on Thu, January 9, 2025

Filed a patent for "use of condensed azacycle compounds for the treatment of lysosomal storage disorders" on Thu, February 16, 2023

Filed a patent for "sigma ligand compounds and uses thereof" on Thu, November 14, 2024

Filed a patent for "use of roluperidone in preventing relapse in schizophrenia patients" on Thu, August 17, 2023

Filed a patent for "compositions and methods for treating schizophrenia" on Thu, June 29, 2023

Filed a patent for "(2s)-1-[4-(3,4-dichlorophenyl)piperidin-1-yl]-3-[2-(5-methyl-1,3,4-oxadiazol-2-yl)benzo[b]furan-4-yloxy] propan-2-ol or its metabolite for treating anxiety disorders" on Thu, August 10, 2023

Filed a patent for "methods of using a phenoxypropylamine compound to treat pain" on Thu, January 18, 2024

Filed a patent for "methods of use of cyclic amide derivatives to treat schizophrenia" on Thu, September 1, 2022

Filed a patent for "compositions and methods for treating negative symptoms in non-schizophrenic patients" on Thu, June 22, 2023

Filed a patent for "gastro-resistant controlled release oral dosage forms" on Thu, December 22, 2022